Benzinga has featured looks at many investor favorite stocks over the past week.
Bullish calls included big cloud plays, a leading retailer and a social media giant.
Bearish calls included an electric vehicle leader, a struggling industrial giant and a big pharma.
The broader equity markets are around 3 percent higher than two weeks ago, thanks in part to the largely solid first-quarter results posted so far. Benzinga has continued to feature looks at the prospects for many investor favorite stocks. Here are just a few of this past week's most bullish and bearish posts that may be worth another look.
"Twitter Ad Business Finally Enticing; Morgan Stanley Upgrades" by Elizabeth Balboa shows why Twitter Inc (NYSE:TWTR) could be poised for strong revenue growth.
In "KeyBanc: Microsoft Is One Of The Market's Fastest-Growing, Best Cloud Plays," Shanthi Rexaline examines how Microsoft Corporation (NASDAQ:MSFT) is well-positioned for further upside.
Brett Hershman's "Baird Expects Nike To Reach North American Inflection With New Products" shows why Nike Inc (NYSE:NKE) is upbeat about its innovation and the return to a pull model.
For a look at what Wall Street thinks of the cloud storage giant Dropbox Inc. (NASDAQ:DBX), check out Wayne Duggan's "Dropbox Quiet Period Expires And Analysts Speak Up."
In Jayson Derrick's "Walmart: 3 Reasons Why Argus Is Turning Bullish," see why shares of Walmart Inc (NYSE:WMT) may now appear attractive after they have fallen 20 percent.
Also have a look at "5 ETNs To Play Return Of Market Volatility."
"GE's Earnings Beat Fails To Change This Bear Analyst's Mind" by Jayson Derrick looks at why a prominent bear says there is "absolutely no change" in his stance on General Electric Company (NYSE:GE) after the earnings beat.
In Elizabeth Balboa's "UBS: Changes To Tesla's Automation Process Are 'Concerning'," see why some sell-side analysts remain pessimistic about production at Tesla Inc (NASDAQ:TSLA).
Growth at Procter & Gamble Co (NYSE:PG) wasn't enough to satisfy some expectations, according to "Argus Cites Disappointing Organic Growth In Procter & Gamble Downgrade" by Jayson Derrick.
In "KLR Downgrades 3 E&P Names On Valuation Concerns," Shanthi Rexaline reviews recent downgrades of Continental Resources, Inc. (NYSE:CLR) and its peers.
Elizabeth Balboa's "One Up, One Down: Morgan Stanley Flips Merck, Bristol-Myers Ratings" suggests that a Bristol-Myers Squibb Co (NYSE:BMY) cancer treatment has lost its edge.
Be sure to check out "Finding Value And Dividends In Emerging Markets" as well.
At the time of this writing, the author had no position in the mentioned equities.
Keep up with all the latest breaking news and trading ideas by following Benzinga on Twitter.
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights